Source:http://linkedlifedata.com/resource/lhgdn/association:25603
| Predicate | Object |
|---|---|
| lhgdn:found_in | |
| lhgdn:geneRifSource |
Of medulloblastomas, 76% have immunoreactivity for either alpha- or beta-synuclein or both; no immunoreactivity for gamma-synuclein is seen in medulloblastomas.
|
| lhgdn:mesh_code |
D008527
|
| lhgdn:associationIdType | |
| lhgdn:umls_code |